Molecular mechanism of atractylon in the invasion and migration of hepatic cancer cells based on highthroughput sequencing.
Mol Med Rep
; 25(4)2022 04.
Article
en En
| MEDLINE
| ID: mdl-35119084
ABSTRACT
The aim of the present study was to investigate the molecular mechanisms of atractylon in the inhibition of invasion and migration of hepatic cancer cells. Highthroughput sequencing was used to compare the expression of long noncoding (lnc)RNAs between hepatic carcinoma and healthy controls. A competing endogenous RNA network was constructed. The top significantly differentially expressed lncRNAs were screened and verified by reverse transcriptionquantitative PCR in vitro and in vivo. Small interfering (si)RNA against thymopoietinantisense 1 (TMPOAS1) or coiledcoil domaincontaining 183antisense 1 (CCDC183AS1) overexpression (oe) vectors were transfected into cells following atractylon treatment. Wound healing and Matrigel assays were used to determine the effects of migration and invasion, respectively. Western blot analysis was used to detect the expression levels of invasion and migrationrelated proteins, including Ncadherin, Ecadherin and MMP2. Flow cytometry analysis was used to detect apoptosis. Based on transcriptome sequencing and analysis, the top seven upregulated [(FAM201A, RP11640M9.2, AL589743.1, TMEM51AS1, clathrin heavy chainlike 1 (CLTCL1), TMPOAS1 and LINC00652] and top six downregulated lncRNAs (RP11465B22.5, CCDC183AS1, TCONS_00072529, RP11401F2.3, RP11290F20.1 and TCONS_00070568) were identified. Only TMPOAS1 and CCDC183AS1 were differently regulated by atractylon in vivo. The proliferative ability of HepG2 liver cancer cells decreased, whereas the apoptotic rate improved after atractylon treatment. Notably, the invasive and migratory ability of HepG2 cells significantly declined. In addition, siTMPOAS1 and oeCCDC183AS1 reduced the effect of atractylon in vitro. Atractylon was demonstrated to regulate the expression of TMPOAS1 and CCDC183AS1 and inhibited the invasion and migration of liver cancer cells. Thus, TMPOAS1 and CCDC183AS1 may be potential targets for diagnosis and treatment of hepatic carcinoma.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Sesquiterpenos
/
Movimiento Celular
/
Neoplasias Hepáticas
/
Antineoplásicos Fitogénicos
Límite:
Animals
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Mol Med Rep
Año:
2022
Tipo del documento:
Article